About: covid:PMC7167191

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7167191 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Li, L. Wang, C. Li, X. Xu, D. Zhang, L. Wang, L. Xu, Z. Liu, Y. Zhong, Y. Ren, X. Yao, Z. Dai, J. Ji, D. Wong, V. Zoulim, F.
is schema:about of	named entity 'ANALOGUE' named entity 'HBV INFECTION' named entity 'detection limit' named entity 'cost-effectiveness' named entity 'resistant mutations' named entity 'mutation' named entity 'amino acid' named entity 'HBV' named entity 'HBV' named entity 'Cary, NC' named entity 'primers' named entity 'HBeAg' named entity 'genotype' named entity 'Fosun Pharmaceutical' named entity 'genotypes' named entity 'qPCR' named entity 'Frederick, MD' named entity 'drug resistance' named entity 'clones' named entity 'nucleoside' named entity 'Innogenetics' named entity 'gene' named entity 'Beijing' named entity 'SARS coronavirus' named entity 'PCR' named entity 'gene' named entity 'Chinese' named entity 'hepatitis B virus' named entity 'chronic HBV' named entity 'resistant mutations' named entity 'genome' named entity 'Beijing' named entity 'viral load' named entity 'Ghent' named entity 'CHB' named entity 'HBV' named entity 'replicative capacity' named entity 'gene' named entity 'drug resistance' named entity 'HBV' named entity 'mutation' named entity 'CHB' named entity 'genotype' named entity 'monotherapy' named entity 'genomes' named entity 'drug-resistant' named entity 'nucleoside' named entity 'ethics committee' named entity 'HBV' named entity 'genotype' named entity 'viraemia' named entity 'drug resistance' named entity 'genotypic' named entity 'China' named entity 'tenofovir' named entity 'immune responses' named entity 'Hepatitis B virus' named entity 'clinical trial' named entity 'HBV' named entity 'HCC' named entity 'anti-HBc' named entity 'PCR' named entity 'Early discovery' named entity 'evolution' named entity 'CHB' named entity 'Genotypic' named entity 'monotherapy' named entity 'HBV' named entity 'PCR' named entity 'potency' named entity 'Serum' named entity 'gene' named entity 'HBV' named entity 'ligation' named entity 'cloned' named entity 'alanine transaminase' named entity 'Hepatitis B virus' named entity 'drug-resistant' named entity 'Promega' named entity 'HBV' named entity 'viral replication' named entity 'PCR' named entity 'Multidrug-resistant' named entity 'HBV' named entity 'Hepatitis B virus'

Attributes

Values

Creator

Li, L.
Wang, C.
Li, X.
Xu, D.
Zhang, L.
Wang, L.
Xu, Z.
Liu, Y.
Zhong, Y.
Ren, X.
Yao, Z.
Dai, J.
Ji, D.
Wong, V.
Zoulim, F.

is schema:about of

named entity 'ANALOGUE'
named entity 'HBV INFECTION'
named entity 'detection limit'
named entity 'cost-effectiveness'
named entity 'resistant mutations'
named entity 'mutation'
named entity 'amino acid'
named entity 'HBV'
named entity 'HBV'
named entity 'Cary, NC'
named entity 'primers'
named entity 'HBeAg'
named entity 'genotype'
named entity 'Fosun Pharmaceutical'
named entity 'genotypes'
named entity 'qPCR'
named entity 'Frederick, MD'
named entity 'drug resistance'
named entity 'clones'
named entity 'nucleoside'
named entity 'Innogenetics'
named entity 'gene'
named entity 'Beijing'
named entity 'SARS coronavirus'
named entity 'PCR'
named entity 'gene'
named entity 'Chinese'
named entity 'hepatitis B virus'
named entity 'chronic HBV'
named entity 'resistant mutations'
named entity 'genome'
named entity 'Beijing'
named entity 'viral load'
named entity 'Ghent'
named entity 'CHB'
named entity 'HBV'
named entity 'replicative capacity'
named entity 'gene'
named entity 'drug resistance'
named entity 'HBV'
named entity 'mutation'
named entity 'CHB'
named entity 'genotype'
named entity 'monotherapy'
named entity 'genomes'
named entity 'drug-resistant'
named entity 'nucleoside'
named entity 'ethics committee'
named entity 'HBV'
named entity 'genotype'
named entity 'viraemia'
named entity 'drug resistance'
named entity 'genotypic'
named entity 'China'
named entity 'tenofovir'
named entity 'immune responses'
named entity 'Hepatitis B virus'
named entity 'clinical trial'
named entity 'HBV'
named entity 'HCC'
named entity 'anti-HBc'
named entity 'PCR'
named entity 'Early discovery'
named entity 'evolution'
named entity 'CHB'
named entity 'Genotypic'
named entity 'monotherapy'
named entity 'HBV'
named entity 'PCR'
named entity 'potency'
named entity 'Serum'
named entity 'gene'
named entity 'HBV'
named entity 'ligation'
named entity 'cloned'
named entity 'alanine transaminase'
named entity 'Hepatitis B virus'
named entity 'drug-resistant'
named entity 'Promega'
named entity 'HBV'
named entity 'viral replication'
named entity 'PCR'
named entity 'Multidrug-resistant'
named entity 'HBV'
named entity 'Hepatitis B virus'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software